Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
주식 순위 #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
주가
$1.51
마지막 동기화: 2024-08-26
시가총액
$1.12M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Agile Therapeutics, Inc. (AGRX)

카테고리

Agile Therapeutics, Inc. (AGRX)의 EPS
June 2024 기준 EPS TTM: $-3.23
Agile Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-3.23입니다. 2022년 말에는 회사의 EPS가 $-58.79였으며, 이는 2021년의 EPS $-63.12K와 감소입니다.
Agile Therapeutics, Inc.의 EPS 기록 (2012 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-3.23 -51.86%
2023 $-6.71 -88.59%
2022 $-58.79 -99.91%
2021 $-63.12K 4,786.76%
2020 $-1.29K 73.08%
2019 $-746.20 -35.27%
2018 $-1.15K -36.99%
2017 $-1.83K -10.01%
2016 $-2.03K -26.22%
2015 $-2.76K -2.35%
2014 $-2.82K -11.05%
2013 $-3.17K -38.43%
2012 $-5.15K 0.00%